SVWA
JNJ icon

Sarver Vrooman Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Sarver Vrooman Wealth Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.8K Sell
381
-6
-2% -$1.4K 0.06% 31
2026
Q1 		$94.6K Sell
387
-46
-11% -$10.7K 0.06% 32
2025
Q4 		$89.6K Sell
433
-149
-26% -$29.5K 0.06% 30
2025
Q3 		$108K Hold
582
– – 0.07% 25
2025
Q2 		$88.9K Sell
582
-100
-15% -$15.4K 0.06% 26
2025
Q1 		$113K Buy
+682
New +$107K 0.08% 19

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Sarver Vrooman Wealth Advisors's JNJ Position: Q2 2026 in Review

Sarver Vrooman Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 1.6% in Q2 2026, selling an estimated $1.4K and leaving 381 shares worth $97.8K. The position accounts for 0.06% of the portfolio, ranked #31.

Sarver Vrooman Wealth Advisors first reported a position in JNJ in Q1 2025 and has held it in 6 quarters since. The position peaked at $113K in Q1 2025. 1,411 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Sarver Vrooman Wealth Advisors held 381 shares of Johnson & Johnson worth $97.8K as of Q2 2026.
  • Sarver Vrooman Wealth Advisors sold 6 Johnson & Johnson shares in Q2 2026, an estimated $1.4K.
  • Johnson & Johnson made up 0.06% of Sarver Vrooman Wealth Advisors's portfolio in Q2 2026, its #31 holding.
  • Sarver Vrooman Wealth Advisors first reported a position in Johnson & Johnson in Q1 2025 and has held it in 6 quarters since.
  • Sarver Vrooman Wealth Advisors's Johnson & Johnson position peaked at $113K in Q1 2025.
  • 1,411 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Sarver Vrooman Wealth Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.